TOXICOLOGICAL SCIENCES 109(2), 217–227 (2009)
doi:10.1093/toxsci/kfp038
Advance Access publication February 20, 2009




Antioxidant Responses NRF2 Synergistic Developmental Toxicity
                        PAHs Zebrafish
               Alicia R. Timme-Laragy,*,1 Lindsey  Van Tiem,* Elwood  Linney,*,† Richard T. Di Giulio*,2
*Integrated Toxicology Environmental Health Program, Nicholas School Environment, Duke University, Durham, NC 27708; †Department                               Molecular Genetics Microbiology, Duke University Medical Center, Durham, NC 27710

                                                        Received December 16, 2008; accepted February 4, 2009

                                                                                         enously respiration oxygenating enzymes (Droge, 2003),
   Early piscine life stages sensitive polycyclic aromatic                        oxidative stress result ‘ disruption redox
hydrocarbon (PAH) exposure, cause pericardial effusion
                                                                                         signaling control’’ (Jones, 2006b). mechanism craniofacial malformations. previously reported certain combinations PAHs cause synergistic developmental
                                                                                         toxicity numerous xenobiotics, contributes maladies
toxicity, observed coexposure aryl hydrocarbon                            ranging chemical carcinogenesis neurodegenerative
receptor agonist b-naphthoflavone (BNF) cytochrome P4501A                            diseases (Droge, 2003; Valavanidis et al., 2006). Embryonic
inhibitor naphthoflavone (ANF).  hypothesized                           development especially sensitive oxidative stress, oxidative stress component toxicity. examined                            15 –20  increase ROS tip progenitor cells
induction antioxidant genes zebrafish embryos (Danio rerio)                        premature cell cycle arrest differentiation (Li et al., 2007;
exposed BNF ANF individually, BNF 1 ANF combination,                             Smith et al., 2000). mammals, utero oxidative stress prooxidant positive control, tert-butylhydroperoxide                               alter gene expression persisting adulthood, affecting DNA
(tBOOH). measured total glutathione (GSH) attempted
                                                                                         methylation, increasing cancer susceptibility (Wan Winn, modulate deformities using GSH synthesis inhibitor
                                                                                         2006).  toxicant exposures cause oxidative stress L-buthionine (S,R)-sulfoximine (BSO) increase GSH pools N-acetyl cysteine (NAC). addition, used morpholino                            embryonic development significant health risk.
knockdown expression antioxidant response element                                    Polycyclic aromatic hydrocarbons (PAHs) ubiquitous
transcription factor NRF2 determine alter gene                          contaminants produced incomplete combustion expression increase deformity severity. BNF 1 ANF coexposure                          organic compounds, concentrations increasing significantly increased expressions superoxide dismutase 1 2,                     usage fossil fuels (Van Metre Mahler, 2005). Complex
glutathione peroxidase 1, pi class glutathione-s-transferase,                        mixtures PAHs commonly include  ring
glutamate cysteine-ligase greater extent tBOOH, BNF,                        structures variable interactions aryl
ANF  BSO pretreatment decreased GSH levels, did                           hydrocarbon receptor (AHR) pathway. AHR member worsen deformities, did NAC diminish toxicity. Knockdown
                                                                                         basic helix-loop-helix ARNT-Sim transcription NRF2 increased mortality following tBOOH challenge, pre-
vented significant upregulation antioxidant genes following
                                                                                         factor family (Gu et al., 2000); ligand binding AHR tBOOH BNF 1 ANF exposures, exacerbated BNF                                  upregulates detoxifying enzymes, including cyto-
1 ANF–related deformities. Collectively, findings demonstrate                      chrome P4501A (CYP1A), important metabolism PAHs. antioxidant responses component PAH synergistic                            PAHs excellent agonists AHR, developmental toxicity NRF2 protective prooxidant                    inhibit activity CYP1A. Coexposures PAHs PAH challenges development.                                                   characteristics cause synergistic embryotoxicity charac-
   Key Words: PAH; NRF2; redox; ROS; embryonic development;                              terized craniofacial malformations cardiovascular
glutathione.                                                                             deformities including pericardial effusion (Billiard et al.,
                                                                                         2006; Hodson et al., 2007; Wassenberg Di Giulio, 2004).
                                                                                            PAHs generate ROS production PAH metabolites
  pollutants cause perturbations cellular redox                              include redox-cycling quinones radical cations, generate reactive oxygen species (ROS) (Livingstone,                                 associated DNA damage (Cavalieri 2001; Valavanidis et al., 2006). ROS produced endog-                           Rogan, 1992; Melius, 1984; Miranda et al., 2006).  PAHs
                                                                                         damage mitochondrial DNA perturb mitochondrial
  1
     Present address: Biology Department, Woods Hole Oceanographic                       function, enhance oxidative stress Institute, Woods Hole, MA 02543
  2
     correspondence addressed Duke University,
                                                                                         organelles (Li et al., 2003; Zhu et al., 1995). Induction Research Drive, Levine Science Research Center, Room A346, Durham, NC                    CYP450s AHR compounds chlorinated
27708-0328. Fax: (919)-668-1799. E-mail: richd@duke.edu.                                 dioxins PCBs lead ROS generation oxidative
Ó Author 2009. Published Oxford University Press behalf Society Toxicology. rights reserved. permissions, email: journals.permissions@oxfordjournals.org
 218                                                   TIMME-LARAGY ET AL.


damage (Nebert et al., 2000; Schlezinger Stegeman, 2001),                          MATERIALS METHODS
associated recalcitrance compounds metabolism. Numerous PAHs induce CYP450s                 Chemicals. chemicals ANF, BNF, N-acetyl cysteine (NAC),
                                                                   L-buthionine  (S,R)-sulfoximine (BSO), GSH, naphthalene dicarboxaldehyde
AHR, induction thought generate ROS
                                                                   (NDA), n-ethylmorpholine, triscarboxyethylphosphine, tBOOH se, suitability PAHs CYP substrates.          obtained Sigma Aldrich (St, MO). Dimethyl sulfoxide (DMSO),  ROS generation enhanced coexposures             potassium hydroxide, sodium hydroxide purchased Mallinckrodt PAHs include AHR agonists CYP inhibi-            Baker (Phillipsburg, NJ). Sulfosalicyclic acid obtained Ricca
tors, exposures rise synergistic embryotoxicity      Chemical Company (Arlington, TX). ANF BNF dissolved DMSO
                                                                   kept protected light  20°C vortexed prior use. NAC (Billiard et al., 2006; Wassenberg Di Giulio, 2004).
                                                                   BSO dissolved 30  Danieau water, NAC pH adjusted 7.0
   studies observed indications oxidative stress   stored  20°C; BSO stored 4°C. fish exposed PAHs. Rainbow trout larvae exposed                                                                       Animals. Zebrafish embryos collected 1 h following mating alkylated-PAH retene reduced glutathione (GSH):
                                                                   AB strain adults  laboratory Dr Elwood Linney Duke University
glutathione disulfide ratios body vitamin E          Zebrafish International Research Consortium Eugene, 
centrations (Bauder et al., 2005). Killifish PAH-           maintained 28°C 14-h light, 10-h dark light cycle. Adults fed
contaminated Superfund site elevated total GSH             TetraMin flake food brine shrimp. Embryos maintained 30 
mitochondrial lipid peroxidation (Bacanskas et al., 2004).         Danieau water (Nasevicius Ekker, 2000) temperature                                                                    photoperiod conditions.
Laboratory-raised progeny site better equipped reference site F1s withstand oxidative stress,           Exposure gene expression experiments. 24 hours post fertilization
increased survival times tert-butylhydroperoxide (tBOOH),       (hpf), embryos dosed replicate pools embryos,                                                                    replicates treatment, 20-ml glass vials containing 7.5 ml 30  Danieau
total GSH, MnSOD protein, GSH reductase activity
                                                                   water. Final DMSO concentration 0.03 . Coexposure experiments
(Meyer et al., 2003). Altered antioxidant defenses, indi-       consisted exposures DMSO, 1 lg/l BNF  100 lg/l ANF 
cation oxidative stress, appear acting response     1 lg/l BNF þ 100 lg/l ANF combination, sampled RNA 48 96
PAH exposure.                                                      hpf. Coexposure experiments repeated times, data
   antioxidant defenses respond antioxidant            point represents n 12 pools embryos. dose-response analysis
                                                                   BNF sampled 48 hpf included concentrations 0, 1, 10, 50, response element   transcription factor, NF-E2 p45–
                                                                   100 lg/l; concentration 50 lg/l caused slight increase pericardial
related factor 2 (NRF2), member cap‘n’collar basic        effusion, 100 lg/l embryos appeared similar 1 lg/l BNF þ
region-leucine zipper transcription factors. unstressed      100 lg/l ANF coexposures 96 hpf (Billiard et al., 2006). Dose-response
conditions, NRF2 constitutively bound Kelch-like ECH–        experiments repeated twice, data point represents n associated protein 1 (KEAP1) cytoplasm targeted     pools embryos. Embryos left original dosing
                                                                   solutions duration experiments. model prooxidant tBOOH
degradation (Nguyen et al., 2003a). ROS detected                                                                    used positive control. pools embryos dosed 24
KEAP1 redox-responsive signaling pathways (Cullinan          hpf glass scintillation vials 7.5 ml 30  Danieau water containing Diehl, 2006; Cullinan et al., 2003; Huang et al., 2000;        0 500lM tBOOH; exposure repeated 3 h prior fixation 48 hpf
Kong et al., 2001; Zipper Mulcahy, 2003), NRF2                 order run parallel tBOOH survival experiments allow sufficient
translocates nucleus, associates small MAF             time transcription response second dose. death deformities
                                                                   observed time point. sampling, embryos rinsed proteins, binds AREs promoter regions set
                                                                   30  Danieau water manually dechorionated necessary, fixed cytoprotective genes (Kobayashi et al., 2006). pathway     RNA later (Ambion, Foster City, CA), stored  80°C. conserved zebrafish (Kobayashi et al., 2002; Li et al.,
                                                                      Total RNA extraction reverse transcription. RNA extractions 2008), NRF2 shown upregulated AHR
                                                                   carried according RNA easy MicroKit Protocol (Qiagen, Valencia,
activation mice (Miao et al., 2005).                            CA). RNA quantity quality analyzed spectrophotometrically using
   hypothesized oxidative stress component     NanoDrop ND-1000 (NanoDrop Technologies, Wilmington, . developmental toxicity PAH mixtures. Zebrafish embryos          Omniscript complementary DNA (cDNA) synthesis kit Reverse Transcrip- exposed combination oxygen-substituted            tion (Qiagen) used according manufacturer’s instructions using 500
                                                                   ng RNA, random hexamers, RNAse inhibitor carried model PAHs shown result synergistic toxicity, AHR
                                                                   thermocycler 1 h 37°C. Resulting cDNA diluted working
agonist b-naphthoflavone (BNF), CYP1A inhibitor              concentration 2 ng/ll.
naphthoflavone (ANF) (Billiard et al., 2006). examined
                                                                      Quantitative real-time PCR. b-Actin primers designed using Light
expression antioxidant genes, total GSH,                                                                    Cycler Probe Design software (Roche, Indianapolis, . Primers gstp1, redox state modulate pericardial effusion.        gstp2, gclc designed using PrimerQuest software (Integrated DNA knocked NRF2 asked exacerbated          Technologies, , www.idtdna.com). high sequence similarity deformities. results support oxidative stress component   gstp1 gstp2 (90.4  sequence similarity), conserved regulatory elements, synergistic developmental toxicity PAH mixtures      inconsistent results previously published primers (Suzuki et al., 2005),
                                                                   designed primers amplify homologs 
identify protective role NRF2 embryonic oxidative
                                                                   henceforth referred gstp. Sod2, Sod1, gpx1 primers published
stress.  precise role oxidative stress           previously (Malek et al., 2004). Primer efficiencies tested ensure
cardiovascular deformities BNF þ ANF coexposures            housekeeping target genes amplified rate. sequences
remains unclear.                                                   employed listed Table 1.
                                                  ANTIOXIDANT RESPONSES NRF2 ZEBRAFISH                                                               219

                                                                  TABLE 1
                                              Primer GenBank Accession Numbers QRT-PCR

Gene                         GenBank ID                                  Forward primer (5#–3#)                                 Reverse primer (5#–3#)

b-Actin               AF057040                                 ACATCCGTAAGGACCTG                                        GGTCGTTCGTTTGAATCTC
Sod1                  Y12236                                   CGCATGTTCCCAGACATCTA                                     GAGCGGAAGATTGAGGATTG
Sod2                  AW07696                                  CTAGCCCGCTGACATTACATC                                    TTGCCCACATAGAAATGCAC
Gpx1                  AW232474                                 AGATGTCATTCCTGCACACG                                     AAGGAGAAGCTTCCTCAGCC
Gstp                  NM_131734; NM_199277                     TCTGGACTCTTTCCCGTCTCTCAA                                 ATTCACTGTTGCCGTTGCCGT
Gclc                  NM_199277                                AACCGACACCCAAAGATTCAGCACT                                CCATCATCCTCTGGAAACACCTCC


   25 ll reaction contained 200nM primer, 12.5 ll 23 Sybrgreen          induction messenger RNA (mRNA) comparing CT target gene
Lightcycler Master Mix (Applied Biosystems, Foster City, CA), 9.5 ll dH2O,        reference gene (b-actin). Reference gene expression 4 ng cDNA template. quantitative real-time PCR (QRT-PCR) carried      altered treatment. technical replicate averaged prior data ABI 7300 quantitative real-time PCR machine following thermal     analysis. fold change obtained biological replicate pool cycle: 10 min 95°C, followed 40 replicates 15 s 95°C, 1 min   embryos averaged treatments; 6–15 replicates used obtain final
60°C, followed dissociation curve. samples run duplicate.        induction averages standard error treatment time point.
   QRT-PCR data analyzed using ABI PRISM 7000 Sequence
Detection  Version 1.1 (Applied Biosystems). comparative CT               GSH quantification. Total GSH (GSH þ glutathione disulfide [GSSG])
method (Livak Schmittgen, 2001) used determine average fold            levels quantified pools 25 embryos 72 hpf exposed




  FIG. 1. Increase expression 48 96 hpf antioxidant genes gclc, gstp, gpx1, sod1, sod2 zebrafish embryos coexposed BNF ANF, compound  compared DMSO controls. exposures began 24 hpf. *p  0.003. Data presented mean þ SEM, n 12.
 220                                                                 TIMME-LARAGY ET AL.
 DMSO, 1 lg/l BNF, 100 lg/l ANF, BNF þ ANF 48 72 hpf                                        TABLE 2
included replicates doses pretreated 24 hpf   Fold Changes mRNA 48 hpf tBOOH (0.5mM) Compared
100lM NAC 1000lM BSO. Embryos washed Danieau water                                                                                      Induction BNF 1 ANF (1 1 100 mg/l) Coexposure
snap frozen liquid nitrogen stored  80°C analysis. used plate reader assay based reaction NDA GSH c-GC form
highly fluorescent cyclized products quantify total GSH (White et al., 2003).    Gene                           tBOOH                             BNF þ ANF
Fluorescence read plate reader (FLUOstar OPTIMA, BMG Labtech,
Offenburg, Germany) excitation 470 nm emission 520 nm,              gclc                          2.8   ±   0.5                        4.6   ±   1.8
quantified based linear standard curve corrected protein content.      gstp                          6.7   ±   1.3                       10.7   ±   2.8
Protein measured using BioRad Protein microtiter plate assay           gpx1                          3.2   ±   0.6                        4.1   ±   1.3
BioRad Protein Assay dye reagent concentrate (Hercules, CA), bovine serum           sod2                          1.6   ±   0.3                        2.9   ±   0.7
albumin standards, absorbance 595 nm.                                        sod1                          1.4   ±   0.3                        2.6   ±   0.8

    Redox modulation deformity experiments. experiments tested              Bold text indicates significant inductions compared respective vehicle pretreatment GSH-modulating chemical, NAC BSO,              controls (p < 0.05). n 12 pools embryos.
alter severity pericardial effusion resulting BNF þ ANF coexposures.
Embryos pretreated 24 48 hpf supplemented daily BSO NAC static 1 lg/l BNF þ 100 lg/l ANF coexposure 48                                               RESULTS
120 hpf. PAH exposure experiments 24 h later gene expression experiments, respect deformities, difference    Upregulation Antioxidant Genes embryos dosed 24 48 hpf (Timme-Laragy,
unpublished results). Dosing conducted triplicate 20 ml glass                   examined induction antioxidant genes scintillation vials containing pools embryos total volume           quantitative real-time PCR, prior onset deformities 7.5 ml 30  Danieau water, final DMSO concentration 0.03            48 hpf, deformity development 96 hpf, zebrafish
groups. 120 hpf, embryos washed Danieau water, anesthetized
                                                                                    embryos exposed dose BNF þ ANF results MS-222, mounted 3  methylcellulose, imaged left lateral
orientation 350 magnification (Zeiss Axioskop, Thornwood, NY.).               synergistic developmental toxicity. observed significant deformities including craniofacial malformations                fold-change induction (p  0.003) BNF þ ANF
truncation Meckel’s cartilage observed measured,          coexposure groups compared vehicle controls gclc, gstp, pericardial effusion robust corollary indicator     gpx1, sod1, sod2 48 hpf 96 hpf (Fig. 1). 48
severity related deformities (Billiard et al., 2006). Pericardial effusion
                                                                                    hpf, gstp exhibited highest induction 10.7-fold, followed
area quantified using IP Lab software (Scanalytics , Fairfax, VA) normalized control pericardial area described previously (Billiard et al.,    gclc 4.6-fold; inductions synergistic
2006). BSO experiments included nontoxic BNF þ ANF combination             factor ANOVA interaction terms 0.02 0.03). lower dose ANF (50 instead 100 lg/l) determine       highest response 4.1-fold increase gpx1. Sod2 exacerbation deformities; analyzed 72 120 hpf.              sod1 responsive, induced 2.9- 2.6-
   Embryo morpholino injection. used morpholino (Gene Tools,                   fold, respectively. Individual doses BNF (1 lg/l) ANF
Philomath,  designed previously block initiation             (100 lg/l) did result significant induction translation zebrafish NRF2 mRNA, (5#-CATTTCAATCTCCATCATGTCT-
CAG-3#) (Kobayashi et al., 2002). Gene Tools’ standard control morpholino
(5#-CCTCTTACCTCAGTTACAATTTATA-3#) used control
morpholino  MO) experiments. Morpholinos diluted working
stocks 0.1mM 30  Danieau’s solution injection (Nasevicius Ekker, 2000). Injection working stocks stored 4°C heated 5 min 65°C prior use. morpholinos tagged 3#-end
carboxyfluorescein modification order monitor injection success.
   Newly fertilized embryos  cell stage  approximately
1 hpf) injected approximately 3 nl morpholino using Narishige
IM300 Microinjector (Tokyo, Japan). healthy embryos exhibiting strong,
uniform fluorescence 24 hpf subsequently used experiments.
   Prooxidant survival exposures. tBOOH survival experiments,
embryos sorted individual wells 96 plate 24 hpf 200
ll 30  Danieau water. Noninjected, control morpholino–injected, NRF2 morpholino–injected embryos exposed concentrations 0, 0.1,
0.5, 0.75, 1, 2mM tBOOH 48 72 hpf. Cumulative mortality analyzed 96 hpf.
   Statistical analysis. Data analyzed Statview Windows
(version 5.0.1; SAS Institute, Cary, NC). ANOVA used determine
significant factors. ANOVA yielded significance (p < 0.05), Fisher’s              FIG. 2. antioxidant genes gstp, gpx1, gclc, sod2 induced protected significant differences used post hoc test. Data       dose-dependent manner following 24-h exposure BNF 48 hpf zebrafish
presented mean ± SEM, n defined number pools 25             embryos. inductions gclc, sod1, sod2 additionally plotted
embryos. LC50 95  confidence intervals tBOOH exposures                 appropriate viewing scale (right). Following significant ANOVAs
calculated using probit analysis SPSS software (SPSS 15.0, SPPS              (p  0.03), Fisher’s protected significant differences significance Chicago, .                                                                       control noted (*p  0.04). Data presented mean ± SEM n 6.
                                                 ANTIOXIDANT RESPONSES NRF2 ZEBRAFISH                                                               221




  FIG. 3. Total GSH quantification 72 hpf, 100lM NAC 1mM BSO. NAC BSO treatments spanned 24–72 hpf PAH vehicle control treatments spanned 48–72 hpf. factor ANOVA pretreatment, BNF, ANF showed significant effect NAC (p ¼ 0.03) BSO (p < 0.0001). *indicates significant difference (p  0.05) NAC BSO pretreatment GSH levels compared pretreatment controls exposure group; mean þ SEM; n ¼ 3 pools 25 embryos.


 genes. significant differences antioxidant gene
induction observed deformity onset 96 hpf
time point, unlike constant activation AHR, continues upregulate cyp1a, cyp1b1, cyp1c1, ahrr2 96
hpf time points (Timme-Laragy et al., 2007).
   Significant inductions gstp, gpx1, gclc observed 48 hpf embryos exposed sublethal dose tBOOH (0.5mM; mortality time point), induction
levels similar observed 48 hpf
BNF þ ANF embryos (Table 2). induction antioxidant
genes indicative redox signaling perturbations, ROS,  oxidative damage.
   previous work showed exposure 1 lg/l BNF þ                           FIG. 4. Pretreatment varying doses (lM) NAC did rescue
100 lg/l ANF mimicked AHR-regulated gene induction                        pericardial effusion, BSO did worsen  Pericardial effusion areas higher, single doses BNF (50 100 lg/l), suggesting                        BNF þ ANF exposures significantly higher DMSO controls (*p 
                                                                                 0.05). Single doses 1 lg/l BNF 100 lg/l ANF showed significant
alterations metabolism occur mixture toxicity
                                                                                 differences DMSO controls excluded graphs simplicity,
(Timme-Laragy et al., 2007). Increasing BNF exposure resulted                    included statistical analyses. Data presented mean þ SEM; n ¼ 3 dose-response induction gclc, gstp, gpx1, sod2                       pools embryos, data point representative 30
(p  0.024), sod1 (Fig. 2). highest dose BNF                      embryos.
(100 lg/l) yielded similar  gstp gpx1) lower
levels combination dose.                                                GSH levels approximately 30–40 lmol GSH/lg protein
                                                                                 compared DMSO controls (Fig. 3, p ¼ 0.075–0.093). Pre-
Total GSH Quantification                                                         treatment 100lM NAC, antioxidant increases
   Total GSH measured 72 hpf, time period                         available pools cysteine increase GSH levels, did
followed pretreatment NAC BSO (24–48 hpf)                        increase total GSH concentrations control embryos, did
24 h postadministration BNF þ ANF 48 hpf. Exposures                     elevate levels observed PAH treatment.
BNF, ANF, BNF þ ANF elicited significant differences                      GSH normally present high concentrations, GSH concentrations groups (Fig. 3).                         present inherent difficulty detecting statistically sig- exposures trended increase total                     nificant increase samples.  experiments
 222                                                               TIMME-LARAGY ET AL.




   FIG. 5. Toxicity nontoxic combination BNF þ ANF exacerbated pretreatment 1000lM BSO 72 120 hpf. statistically
significant differences observed pericardial effusion treatment groups, including single exposure 1 lg/l BNF 50 lg/l ANF, excluded graph simplicity. Data presented mean þ SEM, n ¼ 3 pools embryos.


measured total GSH embryos, mask                             experiments did examine effect NRF2 knockdown important tissue-specific changes.                                                embryo survival prooxidant exposure. did Kobayashi
   BSO inhibits rate-limiting enzyme GSH synthesis,                        et al. (2002), observed injection NRF2 morpholino
glutamate-cysteine ligase, preventing replacement                      concentrations 0.1 0.25mM effect normal
GSH pools hindering GSH response oxidative stress.                     embryonic development (data shown). challenging
BSO did decrease GSH control treatments,                     NRF2- versus control morpholino–injected embryos significant lower total GSH levels observed BSO                     model prooxidant tBOOH, observed statistically signif-
BNF BNF þ ANF groups compared pretreatment                            icant shift 48-h LC50 96 hpf 891lM control
(Fig. 3, p ¼ 0.001), indicating accelerated depletion GSH                   morpholino 586lM NRF2 morpholino–injected embryos increased utilization endogenous antioxidant peptide.                 (Table 3). indicates knockdown NRF2  supports hypothesis oxidative events occurring                  centration (0.1mM) injection volume (3–5 nl) sufficient toxicity, BNF effect                   render fish sensitive toxic effects specific synergistic toxicity.                                             prooxidant.

Redox Modulation Deformities                                                  NRF2 Knockdown Gene Expression
   experiments, embryos pretreated redox-                       examined effectiveness NRF2 morpholino
modulating chemical determine reduced                        knock antioxidant genes following chemical
oxidized redox level alter deformity severity resulting                     exposure. Following dose 500lM tBOOH 24 hpf exposure BNF þ ANF. Pretreatment NAC                              3 h prior sampling 48 hpf  death nontoxic doses 50 100lM did prevent deformities,                       deformities observed time point), noninjected 500lM worsened pericardial effusion BNF þ ANF–                         control morpholino embryos exposed tBOOH showed sig-
treated embryos (Fig. 4). Controls treated 500lM NAC                         nificant upregulation gstp, gpx1, gclc levels indis-
began signs toxicity indicated slight increase                 tinguishable (Fig. 6). genes pericardial effusion thinning lower jaw tissue. highest dose used, 1000lM, fatal (data shown).                                                       TABLE 3
   Pretreatment BSO failed worsen deformities                       Hour LC50s 96 hpf Confidence Intervals nontoxic doses used (10, 100, 1000lM) (Fig. 4).                            Noninjected, Control Morpholino–Injected, NRF2  studies used nontoxic combination BNF þ                           Knockdown Embryos Exposed Prooxidant tBOOH 48
ANF (1 lg/l BNF 50 lg/l ANF) previously shown                                                        72 hpf
exhibit toxicity injection CYP1A-morpholino
(Billiard et al., 2006), did reveal deformity exacerbation                                              LC50 (mM tBOOH)             95  Confidence intervals GSH depletion (Fig. 5).
                                                                                  Noninjected                      0.816                     (0.675, 0.948)
NRF2 Knockdown tBOOH Survival                                                 Control morpholino               0.891                     (0.735, 1.095)
                                                                                  NRF2 morpholino                  0.586*                    (0.459, 0.705)
  NRF2 morpholino sequence pre-
viously described verified (Kobayashi et al., 2002),                      Significant difference (*) injected control.
                                             ANTIOXIDANT RESPONSES NRF2 ZEBRAFISH                                                       223




   FIG. 6. Induction gene expression tBOOH inhibited NRF2 knockdown 48 hpf embryos exposed tBOOH 24 hpf 3 h prior fixation. *p  0.05.


 induced tBOOH-exposed NRF2-MO embryos (Fig. 6).                    NRF2 protective prooxidant PAH exposures Following exposure control NRF2 morpholino–injected                 development.
embryos DMSO, 1 lg/l BNF, 100 lg/l ANF, BNF þ                         shown antioxidant genes sod1, sod2, gstp,
ANF combination, significant interaction               gpx1, gclc upregulated 48 hpf coexposure 1
treatment morpholino (p  0.003) significant induction             lg/l BNF þ 100 lg/l ANF, affected genes examined control morpholino groups                doses  data indicate signaling
exposed BNF þ ANF (sod1, sod2, gstp, gpx1, gclc;                    pathways sensitive redox perturbations responding
Fig. 7, p  0.0035). induction genes                      BNF þ ANF prior deformity onset 48 hpf. appears significantly inhibited NRF2 knockdown (Fig. 7,                    transient response 96 hpf, following onset p  0.0008).                                                               pericardial effusion craniofacial malformations                                                                            BNF þ ANF treatments, expression genes returned
NRF2 Knockdown Deformities                                             control levels. contrast AHR-regulated genes
   Having confirmed effectiveness morpholino             remain elevated time point (Timme-Laragy et al.,
ability render embryo sensitive oxidative stress            2007). inhibit antioxidant gene induction, tested                    induction antioxidant genes synergistic
hypothesis NRF2 plays protective role synergistic            toxicity occurred significant change total GSH,
developmental toxicity PAHs. predicted knockdown                abundant cellular defenses oxidative NRF2 exacerbate deformity severity caused                      stress important cofactor phase II metabolism. toxicity BNF þ ANF. Using combination BNF (1 lg/l)                 studies observed increased GSH PAH exposure fish ANF (50 lg/l) does cause pericardial effusion              (Meyer et al., 2003; Wassenberg, 2004). did significantly
noninjected embryos, examined knockdown                      increase total GSH levels pretreatment NAC NRF2 able exacerbate toxicity. NRF2 knockdown                       controls, NAC pretreatment did exceed levels
exacerbated pericardial effusion 35  lower dose             induction treatments BNF ANF. ANF combination BNF (p  0.05, Fig. 8), indicating                 fact GSH itself negative regulator fully functional antioxidant response utilizing NRF2                modifier subunit glutamate-cysteine ligase, rate-limiting protective synergistic developmental toxicity                enzyme GSH synthesis (Di Giulio Meyer, 2008), BNF þ ANF.                                                                 maintaining limit maximum GSH content. Pericardial
                                                                           effusion reduced NAC.                                                                             high concentrations, NAC appeared actually exacerbate
                           DISCUSSION                                      deformities.
                                                                              GSH levels fish model, channel catfish,    previously demonstrated AHR mediates                    shown difficult modulate BSO  requiring
synergistic embryotoxicity BNF þ ANF CYP1A                  additional stressor deplete total GSH concentrations
protective (Billiard et al., 2006). understand              (Gallagher et al., 1992). Similarly, BSO pre-
mechanism toxicity, looked genes downstream              treatment groups exposed additional stressor AHR cytochrome P450s play role.                   BNF BNF þ ANF showed depletion GSH, evidence NRF2 candidate, AHR-binding xenobiotic              oxidative events occurring. BNF effect response elements (XREs) promoter mouse,              specific synergistic toxicity, suggested shown upregulated TCDD (Miao et al., 2005).              lack GSH depletion deformity severity. current study demonstrates antioxidant responses                 prooxidants shown cause similar defor-
acomponent PAH synergistic developmental toxicity              mities produced BNF þ ANF early life stages  224                                                             TIMME-LARAGY ET AL.




   FIG. 7. Inhibited upregulation antioxidant genes 48 hpf NRF2 knockdown (NRF2-MO) compared control morpholino  MO)–injected embryos 24-h exposure DMSO, 1 lg/l BNF, 100 lg/l ANF, combination BNF þ ANF. significant interaction injection treatment
(p  0.003) way ANOVAs. (*p  0.004; mean þ SEM, n ¼ 3).




fish, cumene hydroperoxide killifish (Wassenberg,                   measurement parameter experiments, important
2004) ethanol zebrafish (Reimers et al., 2004).                 thiol/disulfide antioxidant compartments exist: cysteine/cystine
absence deformities nontoxic NAC BSO                             extracellular space, thioredoxin-1 (-SH2/-SS-). pretreatment experiments does mean oxidative stress                   independently controlled necessarily important factor BNF þ ANF toxicity. Oxidative                    equilibrate (Hansen et al., 2006; Jones,
stress does result gross deformities. example,               2006a,b; Jones et al., 2004). Methods evaluate prooxidant paraquat failed produce deformities                       redox ratios zebrafish embryos useful,
rainbow trout larvae (Bauder et al., 2005), did                    knowledge, available. predict observe deformities prooxidant tBOOH.                         able detect changes coarse measurement
   Perturbed redox signaling contribute deformities                   total GSH BSO pretreatment BNF exposure, ways independent thiol status (Jones, 2006b).                   able examine redox compartment ratios GSH status, specifically GSH:GSSG                     significant changes indicative oxidative
                                                 ANTIOXIDANT RESPONSES NRF2 ZEBRAFISH                                                  225

                                                                                    genes XRE AREs including
                                                                                 sod1, nqo1, ugt1a, gsta (Nguyen et al., 2003b).                                                                                  addition, chemicals, including PAHs BNF                                                                                  benzo pyrene, designated bifunctional inducers,
                                                                                 metabolism AHR-XRE–regulated induction                                                                                  CYP1A form reactive metabolites lead induction                                                                                  NRF2 regulated genes (Nguyen et al., 2003b). gene
                                                                                 expression data showed antioxidant genes examined
                                                                                 induced NRF2 knockdown embryos; similar results
                                                                                 shown mammalian piscine literature
                                                                                 (Kobayashi Yamamoto, 2005; Kobayashi et al., 2004;
                                                                                 Rushmore Kong, 2002; Zhu et al., 2005). fact                                                                                  NRF2 knockdown prevented upregulation genes                                                                                  exposure PAHs prooxidant suggests                                                                                  important response element promoters.
                                                                                    Knocking NRF2 increased sensitivity tBOOH
                                                                                 (decreased LC50) synergistic PAH toxicity
                                                                                 (enhanced pericardial effusion). studies support
                                                                                 protective role NRF2 ROS PAH toxicity.                                                                                  NRF2/ mice, cardiac fibroblasts newly born pups
   FIG. 8. Quantified pericardial effusion 96 hpf. dose does cause
                                                                                 shown lower expression/antioxidant activity
pericardial effusion noninjected (NI) fish, NRF2 morpholino (NRF2-
MO) embryos, toxicity exacerbated results moderate pericardial         catalase, glutathione-s-transferase, NAD(P)H quinine oxi-
effusion. Significant differences noted DMSO controls NI        doreductase 1, glutathione reductase, lower GSH levels
treatment–matched group (*p  0.003). Data presented mean þ SEM,          (Zhu et al., 2005). cells sensitive n ¼ 20–30 fish.                                                                  cytotoxic effects ROS reactive nitrogen species.                                                                                  evidence seen adult NRF2/ mice,                                                                                  susceptible oxidative damage PAHs diesel exhaust.
stress.  signaling occur independent                    mice shown increased rates GSH:GSSG status Trx-1  et al., 2004), changes                       stomach neoplasia following exposure benzo pyrene
antioxidant gene expression sufficient method                  (Ramos-Gomez et al., 2001) accelerated 8-oxo-DG DNA
capture significant perturbations redox status.                               adduct formation lungs mice exposed diesel exhaust
   understand antioxidant responses factor                           (Aoki et al., 2001).
deformities toxicity, cast wider net                          conclusion, antioxidant responses, redox-responding capability embryo knocking                       taken indication oxidative stress, component transcription factor NRF2. doing  prevented                     synergistic developmental toxicity BNF þ ANF upregulation antioxidant genes examined                      specify protective role NRF2 prooxidant PAH
exacerbated pericardial effusion.  deformity                    exposures.  contribution oxidative stress mildly enhanced, suggesting oxidative stress                  development related deformities remains unclear. Additional component synergistic toxicity, precise role                    studies necessary understanding role contributing deformities remains unclear.                                     oxidative stress developmental toxicity PAHs early
   AREs present phase II genes; XREs                    life stages fishes possibly vertebrates. phase phase II genes (Rushmore Kong, 2002). mediators xenobiotic detoxification previously thought function independently, recent                                              FUNDING
identification functional XREs promoter region NRF2 (Miao et al., 2005) caused assumption                       National Institute Environmental Health Sciences–
reevaluated. Knockdown AHR mouse cell lines abolished                      supported Duke University Superfund Basic Research Program
NRF2 induction TCDD. Site-directed mutagenesis showed                         (P42 ES10356), National Institute Environmental Health XRE NRF2 promoter region                        Sciences–supported Duke University Integrated Toxicology &
result mRNA induction NRF2 TCDD, AHR                            Environmental Health Program (TS ES07031), United States shown directly bind NRF2 promoter (Miao et al.,                    Environmental Protection Agency STAR fellowship T.-L.,
2005). Mouse, rat, human NRF2 promoters                             Duke University RJR-Leon Golberg Memorial Postdoctoral
multiple copies XREs (Miao et al., 2005). Little known                     Training Program Toxicology T.-L., Postdoctoral cross-talk fish models.                                            Scholar Program Woods Hole Oceanographic Institution,
 226                                                                TIMME-LARAGY ET AL.

 funding provided J. Seward Johnson Fund                          NF-E2-related factor 2. Proc. Natl Acad. Sci. U.S  97(23),
Walter  Hope Noyes Smith Chair T-L.                                       12475–12480.
                                                                                   Jones, D. P. (2006a). Disruption mitochondrial redox circuitry oxidative
                                                                                     stress. Chem. Biol. Interact. 163(1–2), 38–53.
                                                                                   Jones, D. P. (2006b). Redefining oxidative stress. Antioxid. Redox Signal.
                        ACKNOWLEDGMENTS                                              8(9–10), 1865–1879.
                                                                                   Jones, D. P.,  Y. M., Anderson, C. L., Ziegler, T. R., Kinkade, J. M., Jr.,   authors acknowledge helpful discussions statistical                        Kirlin, W. G. (2004). Cysteine/cystine couple newly recognized node technical assistance Dr Cole Matson Mr Bryan                            circuitry biologic redox signaling control. Faseb. J. 18(11), 1246–1248.
Clark.                                                                             Kobayashi, M., Itoh, K., Suzuki, T., Osanai, H., Nishikawa, K., Katoh, Y.,
                                                                                     Takagi, Y., Yamamoto, M. (2002). Identification interactive
                                                                                     interface phylogenic conservation Nrf2-Keap1  Genes
                                                                                     Cells 7(8), 807–820.
                              REFERENCES                                           Kobayashi, , Kang, M. , Watai, Y., Tong, K. , Shibata, T., Uchida, K.,                                                                                      Yamamoto, M. (2006). Oxidative electrophilic stresses activate Nrf2
Aoki, Y., Sato, H., Nishimura, N., Takahashi, S., Itoh, K., Yamamoto, M.         inhibition ubiquitination activity Keap1. Mol. Cell. Biol. 26(1),
  (2001). Accelerated DNA adduct formation lung Nrf2 knockout          221–229.
  mouse exposed diesel exhaust. Toxicol. Appl. Pharmacol. 173(3), 154–160.      Kobayashi, , Ohta, T., Yamamoto, M. (2004). Unique function Bacanskas, L. R., Whitaker, J., Di Giulio, R. T. (2004). Oxidative stress     Nrf2-Keap1 pathway inducible expression antioxidant   populations killifish (Fundulus heteroclitus) differing contam-        detoxifying enzymes. Meth. Enzymol. 378, 273–286.
  inant exposure histories. Mar. Environ. Res. 58(2–5), 597–601.                   Kobayashi, M., Yamamoto, M. (2005). Molecular mechanisms activating
Bauder, M. B., Palace, V. P., Hodson, P. V. (2005). oxidative stress      Nrf2-Keap1 pathway antioxidant gene regulation. Antioxid. Redox
  mechanism blue sac disease retene-exposed trout larvae? Environ.             Signal. 7(3–4), 385–394.
  Toxicol. Chem. 24(3), 694–702.                                                   Kong,  N., Owuor, E., Yu, R., Hebbar, V., Chen, C., Hu, R., Billiard, S. M., Timme-Laragy,  R., Wassenberg, D. M., Cockman, C.,            Mandlekar, S. (2001). Induction xenobiotic enzymes MAP kinase
  Di Giulio, R. T. (2006). role aryl hydrocarbon receptor pathway      pathway antioxidant electrophile response element  EpRE).
  mediating synergistic developmental toxicity polycyclic aromatic hydro-         Drug Metab. Rev. 33(3–4), 255–271.
  carbons zebrafish. Toxicol. Sci. 92(2), 526–536.                              Li, , Dong, T., Proschel, C., Noble, M. (2007). Chemically diverse
Cavalieri, E. L., Rogan, E. G. (1992). approach understanding              toxicants converge Fyn c-Cbl disrupt precursor cell function. PLoS
  aromatic hydrocarbon carcinogenesis. central role radical cations         Biol. 5(2), e35.
  metabolic activation. Pharmacol. Ther. 55(2), 183–199.                           Li, L  Kobayashi, M., Kaneko, H., Nakajima-Takagi, Y., Nakayama, Y., Cullinan, S. B., Diehl, J.  (2006). Coordination ER oxidative            Yamamoto, M. (2008). Molecular evolution Keap1: Keap1
  stress signaling: PERK/Nrf2 signaling pathway. Int. J. Biochem. Cell            molecules distinctive intervening region structures conserved
  Biol. 38(3), 317–332.                                                               fish. J. Biol. Chem. 283(6), 3248–3255.
Cullinan, S. B., Zhang, D., Hannink, M., Arvisais, E., Kaufman, R. J.,         Livak, K. J., Schmittgen, T. D. (2001). Analysis relative gene expression
  Diehl, J.  (2003). Nrf2 direct PERK substrate effector PERK-         data using real-time quantitative PCR 2(-Delta Delta C(T)) method.
  dependent cell survival. Mol. Cell. Biol. 23(20), 7198–7209.                       Methods 25(4), 402–408.
Di Giulio, R. T., Meyer, J. N. (2004). Reactive oxygen species             Livingstone, D. R. (2001). Contaminant-stimulated reactive oxygen species
  oxidative stress. Toxicology Fishes (R. T. Di Giulio                 production oxidative damage aquatic organisms. Mar. Pollut. Bull.
  D. E. Hinton, Eds.). Taylor Francis, Boca Raton, FL.                           42(8), 656–666.
Droge, W. (2003). Oxidative stress aging. Adv. Exp. Med. Biol. 543,            Malek, R. L., Sajadi, H., Abraham, J., Grundy, M. , Gerhard, G. S.
  191–200.                                                                          (2004). effects temperature reduction gene expression Gallagher, E. P., Hasspieler, B. M., Di Giulio, R. T. (1992). Effects        oxidative stress skeletal muscle adult zebrafish. Comp. Biochem.
  buthionine sulfoximine diethyl maleate glutathione turnover         Physiol. C Toxicol. Pharmacol. 138(3), 363–373.
  channel catfish. Biochem. Pharmacol. 43(10), 2209–2215.                          Melius, P. (1984). Comparative benzo pyrene metabolite patterns fish  Y. M., Gipp, J. J., Mulcahy, R. T., Jones, D. P. (2004). H2O2-              rodents. National Cancer Institute Monograph 65, 387–390.
  dependent activation GCLC-ARE4 reporter occurs mitogen-activated           Meyer, J. N., Smith, J. D., Winston, G. W., Di Giulio, R. T. (2003).
  protein kinase pathways oxidation cellular glutathione              Antioxidant defenses killifish (Fundulus heteroclitus) exposed   thioredoxin-1. J. Biol. Chem. 279(7), 5837–5845.                                  contaminated sediments model prooxidants: Short-term heritable
Gu, Y. , Hogenesch, J. B., Bradfield, C.  (2000). PAS                   responses. Aquat. Toxicol. 65(4), 377–395.
  superfamily: Sensors environmental developmental signals. Annu.           Miao, W., Hu, L., Scrivens, P. J., Batist, G. (2005). Transcriptional
  Rev. Pharmacol. Toxicol. 40(1), 519–561.                                          regulation NF-E2 p45-related factor (NRF2) expression aryl
Hansen, J. M.,  Y. M., Jones, D. P. (2006). Nuclear mitochondrial        hydrocarbon receptor-xenobiotic response element signaling pathway: Direct
  compartmentation oxidative stress redox signaling. Annu. Rev.              cross-talk phase II drug-metabolizing enzymes. J. Biol. Chem.
  Pharmacol. Toxicol. 46, 215–234.                                                  280(21), 20340–20348.
Hodson, P. V., Qureshi, K., Noble, C. , Akhtar, P., Brown, R. S. (2007).     Miranda, C. L., Chung, W. G., Wang-Buhler, J. L., Musafia-Jeknic, T.,
  Inhibition CYP1A enzymes alpha-naphthoflavone causes                    Baird, W. M., Buhler, D. R. (2006). Comparative vitro metabolism   synergism antagonism retene toxicity rainbow trout (Oncorhynchus         benzo pyrene recombinant zebrafish CYP1A liver microsomes   mykiss). Aquat. Toxicol. 81(3), 275–285.                                           [beta]-naphthoflavone-treated rainbow trout. Aquat. Toxicol. 80(2), 101–108.
Huang, H. C., Nguyen, T., Pickett, C. B. (2000). Regulation             Nasevicius, , Ekker, S. C. (2000). Effective targeted gene ‘knockdown’
  antioxidant response element protein kinase C-mediated phosphorylation          zebrafish. Nat. Genet. 26(2), 216–220.
                                                     ANTIOXIDANT RESPONSES NRF2 ZEBRAFISH                                                                   227

Nebert, D. W., Roe,  L., Dieter, M. , Solis, W. , Yang, Y.,                    toxicity exposure model PAHs zebrafish. Aquat. Toxicol.
  Dalton, T. P. (2000). Role aromatic hydrocarbon receptor [Ah]               85(4), 241–250.
  gene battery oxidative stress response, cell cycle control,               Valavanidis, , Vlahogianni, T., Dassenakis, M., Scoullos, M. (2006).
  apoptosis. Biochem Pharmacol. 59(1), 65–85.                                            Molecular biomarkers oxidative stress aquatic organisms relation
Nguyen, T., Sherratt, P. J., Huang, H. C., Yang, C. S., Pickett, C. B. (2003a).      toxic environmental pollutants. Ecotoxicol. Environ. Saf. 64(2),
  Increased protein stability mechanism enhances Nrf2-mediated                 178–189.
  transcriptional activation antioxidant response element. Degradation       Van Metre, P. C., Mahler, B. J. (2005). Trends hydrophobic organic
  Nrf2 26 S proteasome. J. Biol. Chem. 278(7), 4536–4541.                         contaminants urban reference lake sediments United States,
Nguyen, T., Sherratt, P. J., Pickett, C. B. (2003b). Regulatory mechanisms           1970–2001. Environ. Sci. Technol. 39(15), 5567–5574.
  controlling gene expression mediated antioxidant response element.            Wan, J., Winn, L. M. (2006). utero-initiated cancer: role reactive
  Annu. Rev. Pharmacol. Toxicol. 43, 233–260.                                           oxygen species. Birth Defects Res. C 78(4), 326–332.
Ramos-Gomez, M., Kwak, M. K., Dolan, P. M., Itoh, K., Yamamoto, M.,                    Wassenberg, D. M. (2004). Interactive Effects Polycyclic Aromatic
  Talalay, P., Kensler, T. W. (2001). Sensitivity carcinogenesis increased    Hydrocarbons Cytochrome P4501A Activity Embryonic Development
  chemoprotective efficacy enzyme inducers lost nrf2 transcription         Killifish Fundulus heteroclitus. Nicholas School Environment
  factor-deficient mice. Proc. Natl Acad. Sci. U.S  98(6), 3410–3415.                 Earth Sciences, Integrated Toxicology Program, Duke University,
Reimers, M. J., Flockton,  R., Tanguay, R. L. (2004). Ethanol-                Durham, NC.
  acetaldehyde-mediated developmental toxicity zebrafish. Neurotoxicol.             Wassenberg, D. M., Di Giulio, R. T. (2004). Synergistic embryotoxicity   Teratol. 26(6), 769–781.                                                              polycyclic aromatic hydrocarbon aryl hydrocarbon receptor agonists Rushmore, T. H., Kong,  N. (2002). Pharmacogenomics, regulation               cytochrome P4501A inhibitors Fundulus heteroclitus. Environ. Health
  signaling pathways phase II drug metabolizing enzymes. Curr. Drug            Perspect. 112(17), 1658–1664.
  Metab. 3(5), 481–490.                                                                White, C. C., Viernes, H., Krejsa, C. M., Botta, D., Kavanagh, T. J. (2003).
Schlezinger, J. J., Stegeman, J. J. (2000). Induction suppression             Fluorescence-based microtiter plate assay glutamate-cysteine ligase
  cytochrome P450 1A 3,3#,4,4#,5-pentachlorobiphenyl relationship             activity. Anal. Biochem. 318(2), 175–180.
  oxidative stre